Sep 01, 2015 at 16:28 | Source: CNBC-TV18
Guy Stear, Head of Credit Research and Emerging Markets Strategy of Societe Generale says that says that investors jittery about the US Federal Reserve possibly hiking rates this month itself despite the turmoil in global markets.
Aug 31, 2015 at 09:39 | Source: Moneycontrol.com
Aurobindo Pharma has received the final approval from the US Food & Drug Administration (USFDA) to manufacture and market Raloxifene Hydrochloride Tablets USP 60mg (ANDA 204310).
Aug 30, 2015 at 15:02 | Source: PTI
"What we are hearing from our companies that India story is strong. The slowdown in China is making India story much much stronger," Mukesh Aghi, president of the US India Business Council (USIBC) told PTI.
Aug 30, 2015 at 11:51 | Source: PTI
"It is expected that the manufacturing capacity for cells and modules will increase roughly by 2,500 MW and 5,000 MW per annum, respectively. This is expected to create 25,000 jobs in manufacturing sector and bring in investment of about Rs 30,000 crore," said an official in the New and Renewable Energy Ministry.
Aug 27, 2015 at 13:39 | Source: PTI
The company has received final approval from the US Food and Drug Administration (USFDA) to manufacture and market Entecavir tablets in strengths of 0.5mg and 1mg, Aurobindo Pharma said in a statement.
Aug 27, 2015 at 13:28 | Source: Moneycontrol.com
"The company has received the final approval from the USFDA to manufacture and market Entecavir Tablets, 0.5mg and 1mg," it said in a filing to the exchange.
Aug 27, 2015 at 13:12 | Source: Moneycontrol.com
Aurobindo Pharma has received the final approval from the US Food & Drug Administration (USFDA) to manufacture and market Entecavir Tablets, 0.5mg and 1mg (ANDA 206217).
Aug 27, 2015 at 07:54 | Source: CNBC
The recent bout of global risk aversion, triggered by concerns over an impending U.S. rate hike and China's economic slowdown, has had a knock on impact on commodity prices, equities and emerging market currencies - and India hasn't been spared.
Aug 25, 2015 at 21:38 | Source: PTI
The company denied that US Food and Drug Administration has put any restriction on import of Dabur's product in market and would not impact its business there, Dabur said in a filing to the BSE. "USFDA had not put any restriction on import and sale in the US, of products manufactured at Dabur's Alwar unit".
Aug 24, 2015 at 13:51 | Source: Reuters
Asian equities tumbled, the US dollar retreated and industrial commodities from copper to oil slid to their weakest since 2009.